Michael H. Goldstein, MD, MBA, is Co-Director of the Cornea, External Disease service at Tufts University/New England Eye Center and is an assistant professor at Tufts University School of Medicine. He is also Chief Medical Officer at AGTC, an gene therapy company developing therapies for patients with retinal diseases. He has won the Resident Teaching Award at Tufts Medical Center, the American Academy for Ophthalmology Secretariat Award for Education, and the AAO Senior Achievement Award. Dr. Goldstein has been involved with private sector clinical research and biotechnology consulting for over 15 years. Dr. Goldstein attended Williams College, Northwestern University Medical, and the Kellogg Graduate School of Management. Dr. Goldstein also serves as Team Ophthalmologist for the Boston Celtics.